Drug recall D-1546-2022
Product
ClomiPRAMINE Hydrochloride Capsules, USP 25mg, 100-count bottles, Rx only, LEADING PHARMA, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-167-01
Reason for recall
Superpotent Drug: Assay value found to be 110.6% in Chlomipramine Hydrocholoride capsules
Lots and codes
Lot#: B14221, Exp. Date 02/2023
Recall details
- Recalling firm
- Leading Pharma, LLC, Fairfield, NJ
- Quantity
- 960 bottles (100 capsules)
- Distribution
- Nationwide within the United States
- Type
- Voluntary: Firm initiated
- Recall initiated
- August 23, 2022
- Terminated
- September 28, 2023
Related products
- Clomipramine Hydrochloride – drug information
- NDC 69315-166 Clomipramine Hydrochloride · Clomipramine Hydrochloride 50 mg/1 · Leading Pharma, LLC
- NDC 69315-167 Clomipramine Hydrochloride · Clomipramine Hydrochloride 25 mg/1 · Leading Pharma, LLC
- NDC 69315-165 Clomipramine Hydrochloride · Clomipramine Hydrochloride 75 mg/1 · Leading Pharma, LLC